ESC Heart Failure (Oct 2024)

Relation of myocardial dysfunction to biomarkers, COVID‐19 severity and all‐cause mortality

  • Jianxiong Chen,
  • Lin Jin,
  • Mengjiao Zhang,
  • Lingheng Wu,
  • Cuiqin Shen,
  • Jiali Sun,
  • Lianfang Du,
  • Xianghong Luo,
  • Zhaojun Li

DOI
https://doi.org/10.1002/ehf2.14881
Journal volume & issue
Vol. 11, no. 5
pp. 2954 – 2966

Abstract

Read online

Abstract Aims The COVID‐19 infection has been described as affecting myocardial injury. However, the relation between left ventricular global longitudinal strain (GLS), global circumferential strain (GCS) and global radial strain (GRS), disease severity and all‐cause mortality in COVID‐19 is unclear. Methods and Results The study consisted of 220 patients with COVID‐19, including 127 (57.5%) with mild, 43 (19.5%) with moderate and 50 (22.7%) with severe/critical conditions. Myocardial dysfunction was analysed by GLS, GCS and GRS using two‐dimensional speckle‐tracking echocardiography. Hazard ratios and Kaplan–Meier curves were produced to assess the association between strains and cardiac biomarker indices with a composite outcome of all‐cause mortality. With an average follow‐up period of 11 days, 19 patients reached the endpoint (death). Significant associations were found for the three strain parameters and the levels of blood urea nitrogen (BUN) (r = 0.206, 0.221 and 0.355, respectively). Cardiac troponin I (cTnI) was closely related to the GLS and GCS (r = 0.240 and 0.324, respectively). In multivariable Cox regression, GCS > −21.6% was associated with all‐cause death {hazard ratio, 4.007 [95% confidence interval (CI), 11.347–11.919]}. Conclusions GLS, GCS and GRS are significantly related to myocardial dysfunction in patients with COVID‐19. Worsening GCS poses an increased risk of death in COVID‐19.

Keywords